Funding opportunities
2,259 live opportunities from Grants.gov, NIH, NSF, and more.
Biomedical & Health× remove
- Identification of attenuating mutations in the envelope protein for the rational design of a candidate West Nile live-attenuated vaccine.National Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $420,921activenih
- Next Generation Metabolic Signatures of Infectious Causes of Vaginitis: Small Molecule Metabolite-Based Biomarkers for Diagnosis, Test-of-Cure, and Prediction of RecurrenceNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $867,869activenih
- Regulation of Naive Follicular B Cell PolyreactivityNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $778,143activenih
- Naturally Occurring Canine Hemangiosarcoma as a Translational Model for AngiosarcomaNational Cancer InstitutePAR-24-306 closes 5/31/2031up to $635,324activenih
- A Novel Multimodal Approach to Promote Motor Recovery and Plasticity after StrokeEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-305 closes 5/31/2031up to $667,666activenih
- Phage Predation as a Determinant of Diarrheal Disease Severity and Antimicrobial Resistance EmergenceNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $750,263activenih
- Uncovering determinants of pathogenic outcome versus protective responses in filovirus infectionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $817,498activenih
- Advancing NEMO’s specific MRI detection of residual breast cancer using novel imaging platformsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $484,944activenih
- Spatial control of synthetic immunogenic cytotoxicity for the treatment of locally advanced lung cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $682,140activenih
- Estimating and understanding implications of population susceptibility to coccidioidomycosis, an emerging infectious diseaseNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $677,822activenih
- Leveraging Multimodal Signatures to Personalize Rectal Cancer Radiotherapy ChoiceNational Cancer InstitutePA-25-301 closes 5/31/2031up to $518,451activenih
- Reducing ReADmissions through Innovative ApplicatioNs of Telemedicine (RADIANT)National Cancer InstitutePAR-25-167 closes 5/31/2031up to $747,660activenih
- Elucidating the Role of Lactate in Immune Dysfunction during Sepsis: A Focus on B Cell ModulationNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $626,472activenih
- Unraveling the Molecular Mechanisms of Immunotherapy-Associated MyocarditisNational Cancer InstitutePA-25-301 closes 5/31/2031up to $706,739activenih
- Biomimetic Migrating Nanoparticles Targeting Tumor Stroma and Neural Invasion to Improve Pancreatic Cancer Therapy and Pain ControlNational Cancer InstitutePAR-25-106 closes 5/31/2031up to $602,170activenih
- Regulation of antibacterial interferon defense by MiT family transcription factorsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $624,375activenih
- Identifying drug tolerance mechanisms in Mycobacterium tuberculosis glpK mutants to develop better treatments against drug tolerant persister bacilli.National Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $811,772activenih
- Investigating age-dependent factors in the development and treatment of adrenal cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $581,686activenih
- Therapeutic mechanisms of targeting WRN in MSI colorectal cancer.National Cancer InstitutePA-25-301 closes 5/31/2031up to $581,548activenih
- Artificial Intelligence-powered Advanced Ultrasound for Early Diagnosis of Intraocular MelanomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $643,606activenih
- Functions and mechanisms of ILC2s in trained immunityNational Cancer InstitutePA-25-301 closes 5/31/2031up to $684,252activenih
- Epidemiological assessment of Strongyloides stercoralis in at-risk populations in TexasNational Institute of Allergy and Infectious DiseasesPA-24-185 closes 5/31/2031up to $191,219activenih
- Using Trajectory Based Phenotypes to Target Treatment in Pediatric Septic ShockEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-24-185 closes 5/31/2031up to $163,825activenih
- Trained immunity signatures of reduced vaccine responses in older adultsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $932,993activenih
- Modulation of Acute Lung Injury by the Phosphatase SHP1National Heart Lung and Blood InstitutePA-24-182 closes 5/31/2031up to $174,744activenih